Pacira Pharmaceuticals buy Wedbush
Start price
08.02.24
/
50%
€25.80
Target price
08.02.25
€53.03
Performance (%)
-0.78%
End price
09.02.25
€25.60
Summary
This prediction ended on 09.02.25 with a price of €25.60. During the runtime of the prediction for Pacira Pharmaceuticals the price only changed by -0.78%. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 4.737% | 4.737% | -7.870% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Wedbush for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Wedbush gewählte maximale Laufzeit wurde überschritten